Ambu A/S

Equities

AMBU B

DK0060946788

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Copenhagen Other stock markets 11:20:00 2024-12-04 am EST			5-day change	1st Jan Change
111.40 ^DKK	+0.59%		-1.11%	+5.89%

Dec. 04	Ambu A/S - Shareholder/Analyst Call
Nov. 26	Bernstein initiates coverage of Ambu with a market perform recommendation - BN	FW

Ambu A/S : NOTICE OF THE ANNUAL GENERAL MEETING 2024 OF AMBU A/S

November 08, 2024 at 06:46 am EST

English

Published: 2024-11-08 12:15:29 CET

Ambu A/S
Notice to general meeting

NOTICE OF THE ANNUAL GENERAL MEETING 2024 OF AMBU A/S

8.11.2024 12:15:29 CET | Ambu A/S | Notice to general meeting

Notice is hereby given of the annual general meeting of Ambu A/S, CVR no. 63 64 49 19, which is held on

Wednesday, 4 December 2024 at 1:00 pm (CET)

at the company's address at Baltorpbakken 13, 2750 Ballerup.

Board of Directors
The Board of Directors proposes re-election of Jørgen Jensen as Chair of the Board and Shacey Petrovic as Vice Chair.

The Board of Directors proposes that Susanne Larsson, Michael del Prado and Simon Hesse Hoffmann are all re-elected.

Furthermore, the Board of Directors proposes that David Hale be elected as a new member to the Board of Directors.

Christian Sagild has decided not to run for re-election.

The notice for this year's annual general meeting, including information about the proposed Board candidates, is enclosed. This notice is available in Danish and English-language versions. In the event of discrepancies, the English version shall prevail.

Ambu A/S offers the possibility of viewing the annual general meeting 2024 via live webcast on Ambu's website. Please refer to the notice for further information.

Contacts

Anders Hjort, Head of Investor Relations, +45 2892 8881, anhj@ambu.com
Tine Bjørn Schmidt, Head of Corporate Communications, +45 2264 0697, tisc@ambu.com

About Ambu A/S

Since 1937, Ambu has been rethinking solutions, together with healthcare professionals, to save lives and improve patient care. Today, millions of patients and healthcare professionals worldwide depend on the efficiency, safety and performance of our single-use endoscopy, anaesthesia and patient monitoring solutions. Headquartered near Copenhagen in Denmark, Ambu employs around 5,000 people in Europe, North America, Latin America and Asia Pacific.

For more information, please visit Ambu.com.

Attachments:
Download announcement as PDF.pdf
Indkaldelse til ordinr generalforsamling 2024 i Ambu A-S - Selskabsmeddelelse nr. 5 2024-25.pdf
Notice of annual general meeting 2024 of Ambu A-S - Company announcement no 5 2024-25.pdf

This news release was distributed by Company News System, www.nasdaqomxnordic.com/news/marketnotices
To subscribe on regulatory news from this company, go to the subscription page

Attachments

Original document
Permalink

Disclaimer

Ambu A/S published this content on November 08, 2024, and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on November 08, 2024 at 11:42:14.526.

Latest news about Ambu A/S

Ambu A/S - Shareholder/Analyst Call	Dec. 04
Bernstein initiates coverage of Ambu with a market perform recommendation - BN	Nov. 26	FW
Nordea Bank Upgrades Ambu to Buy	Nov. 14	MT
Ambu A/S Announces Christian Sagild, Independent Director Decides Not to Run for Re-Election	Nov. 08	CI
DNB lowers target price for Ambu to DKK 140 (145), reiterates Buy - BN	Nov. 06	FW
Carnegie lowers target price for Ambu to 130 Danish kroner (135), reiterates hold - BN	Nov. 06	FW
Handelsbanken raises Ambu to marketperform (underperform) in the long term, target price SEK 140 (147)	Nov. 06	FW
SEB lowers target price for Ambu to DKK 155 (165), reiterates Buy - BN	Nov. 06	FW
Ambu A/S, Q4 2024 Earnings Call, Nov 05, 2024	Nov. 05
Ambu's organic growth lower than expected	Nov. 05	FW
Ambu A/S Provides Financial Guidance for the Year 2024/25	Nov. 04	CI
Ambu A/S Reports Earnings Results for the Fourth Quarter and Full Year Ended September 30, 2024	Nov. 04	CI
Evaxion Biotech A/S Announces CFO Changes	Sep. 20	CI
SEB raises target price for Ambu to DKK 165 (160), reiterates Buy - BN	Sep. 19	FW
SEB Bank Upgrades Ambu to Buy	Sep. 02	MT
Today's stock recommendations at a glance	Sep. 02	FW
Danske Bank lowers target price for Ambu to DKK 140 (160), reiterates 'Hold' - BN	Sep. 02	FW
DNB raises target price for Ambu to DKK 145 (138), reiterates Buy - BN	Sep. 02	FW
Carnegie lowers target price for Ambu to DKK 135 (144), reiterates hold - BN	Sep. 02	FW
SEB raises Ambu to buy (hold), target price DKK 160 - BN	Sep. 02	FW
JP Morgan raises target price for Ambu to DKK 76 (59), reiterates neutral - BN	Sep. 02	FW
Ambu A/S, Q3 2024 Earnings Call, Aug 30, 2024	Aug. 30
Ambu's final results fully in line with preliminary data	Aug. 30	FW
Ambu A/S Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2024	Aug. 30	CI
Carnegie raises target price for Ambu to DKK 144 (128), reiterates hold - BN	Aug. 23	FW

Chart Ambu A/S

Duration

Period

AMBU B: Dynamic Chart

Company Profile

Ambu A/S is specialized in the design, production and marketing of medical supplies. Net sales break down by family of products as follows: - single-use endoscopes (56.3%); - emergency care and resuscitation devices (22.9%): mechanical ventilation devices (insufflators, laryngeal masks, facial masks and respiratory bags), secretion aspirators, immobilization devices, etc. In addition, the group sells dummies for first aid training centers; - monitoring and diagnostic devices (20.8%): including electrodes used in the fields of cardiology, neurophysiology and first aid. At the end of September 2023, Ambu A/S had four production sites located in China, Malaysia, the United States and Mexico. Net sales are distributed geographically as follows: Denmark (1.2%), Europe (37.8%), the United States (49.5%), North America (1.3%) and other (10.2%).

Employees

5,196

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-12-04 - Détachement de for final dividend

More about the company